Based on our R&D strategy, Focus Area Approach, we concentrate our investments on Primary Focus, and work to develop innovative treatments. We also identify Biology, Modalities/Technology that may become Primary Focus in the future as Primary Focus Candidates. As areas of interest for Astellas, which are much earlier than Primary Focus and Primary Focus Candidates, we are also working on exploratory research.
The following diagram shows how our research and development areas evolve step by step.
Click Read More to see the details of each step.
You can swipe the diagram.
Primary Focus
Primary Focus Candidates
Exploratory Research
Cell Therapy
Focus Area Approach
Astellas has established a Focus Area Approach for its research and development strategy. Specifically, our Focus Area Strategy is defined as combinations of three components: (1) biologies with high disease relevance, (2) versatile modalities/technologies, and (3) diseases with high unmet medical needs that are expected to be tackled by the first two components.
We view this strategy as a way to build a sustainable, expandable drug discovery approach to develop new platforms, leverage expertise and create innovative products. The Focus Area is constantly adapting in response to advances in science and changes in disease treatment paradigms.
In particular, Primary Focus is a specific focal point within our Focus Area Approach where a lead and follow-on projects show a clear R&D path with expected commercial feasibility.
